PZ Cussons plc : Perfect timing to aim a technical rebound
|
08/20/2012 | 03:27am
Opinion : Bullish above 302.4 GBp Target price : 316.2 GBp Stop loss: 299.7 GBp
|
LONDON STOCK EXCHANGE Personal Products |
PZ Cussons, manufacturer of personal healthcare products, shows relatively strong fundamentals and is coming back to attractive price.
However, analysts have revised slightly downward their earnings forecasts. With an EPS estimated at 15.96 cts GBP for this year and 17.83 cts GBP for the next year, PZ Cussons is currently paid 19 and 17.01 times the results.
The security follows a downward trend in the short term, under the GBp 316.2 resistance area. The stock is trading within a range between GBp 302.4 and GBp 316.2. The security is not likely to continue its downtrend because it is near to the strong GBp 302.4 and it is in oversold situation.
Therefore, the proximity of the GBp 302.4 support is an opportunity to take a long position in PZ Cussons. The first goal is a return in the GBp 316.2 resistance area, that is a potential of 4.3 %. In fact, the security has to cross this area in order to re-establish a bullish trend in the short term. A stop loss order can be placed under the support currently tested.
|
|
Copyright (c) 2013 4-Traders.com |
Disclaimer: 4-traders.com is a website published by SURPERFORMANCE SAS. Surperformance or 4-traders.com is not a registered broker-dealer nor a registered investment adviser. You understand that this web site and its content is furnished for your personal, noncommercial, informational purposes only, and that no mention of a particular security in this website constitutes a recommendation to buy, sell, or hold any other security, nor that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Surperformance and 4-traders.com services will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. Information regarding trading and investment as provided by Surperformance professional is not tailored to the investment needs of any specific person. You acknowledge that you are responsible for your own financial decisions and should seek a registered financial agent depending on your own risk tolerance to advise you on your personal trading activities.
|
|
|
|
|
Valuation |
2013e |
2014e |
|
PER (Price / EPS)
|
25,8x |
22,0x |
|
Capitalization / Revenue
|
1,91x |
1,84x |
|
EV / Revenue
|
1,90x |
1,81x |
|
EV / EBITDA
|
13,7x |
12,4x |
|
Yield (DPS / Price)
|
1,86% |
2,06% |
| Profitability |
2013e |
2014e |
|
Operating Margin (EBIT / Sales)
|
12,0% |
12,9% |
|
operating laverage (Delta EBIT / Delta Sales)
|
4,30x |
2,89x |
|
Net Margin (Net Profit / Revenue)
|
7,58% |
8,59% |
|
ROA (Net Profit / Asset)
|
- |
- |
|
ROE (Net Profit / Equities)
|
14,3% |
14,6% |
|
Rate of Dividend
|
47,9% |
45,5% |
|
|
|